MODULAÇÃO AUTONÔMICA DA FREQUÊNCIA CARDÍACA E CAPACIDADE FUNCIONAL AERÓBICA EM HEMIPARÉTICOS

RESUMO Introdução: Tem sido observado que indivíduos acometidos por acidente vascular encefálico (AVE) apresentam, além dos danos físicos, diminuição da capacidade aeróbica e alteração da modulação autonômica da frequência cardíaca, sendo estes importantes fatores para o aparecimento de doenças cardíacas e arritmias. Objetivo: Investigar os efeitos crônicos do AVE sobre a capacidade aeróbica (VO2pico) e os índices de variabilidade da frequência cardíaca (VFC), e se existe correlação entre essas duas variáveis. Métodos: Foram avaliados 11 indivíduos do sexo masculino, com idade entre 55 e 65 anos, acometidos por lesão cerebrovascular há pelo menos seis meses, e todos com hemiparesia. Foram realizadas as seguintes avaliações: teste de capacidade aeróbica máxima; registro dos intervalos R-R e cálculo dos índices da VFC (RMSSD, pNN50, AF, BF e a razão BF/AF). Para comparação entre VO2pico previsto e obtido utilizou-se o teste t de Student não pareado. Para testar a hipótese de correlação entre os índices de VFC e o VO2pico utilizou-se o teste de correlação de Pearson. Resultados: VO2pico (mL.kg-1.min-1) previsto e obtido, respectivamente = 32,15 ± 1,87 e 16,12 ± 5,51; índices da VFC: RMSSD (ms) = 28,69 ± 26,78; pNN50 (%) = 8,76 ± 12,62; AF (u.n.) = 51,96 ± 22,4; BF (u.n.) = 48,04 ± 22,49. O VO2pico correlacionou-se negativamente com os índices RMSSD, pNN50 e AF e positivamente com o índice BF (p < 0,05). Conclusão: Na fase crônica do AVE, variabilidade da frequência cardíaca encontra-se normal e os indivíduos com menor capacidade aeróbica apresentam maior modulação parassimpática e menor simpática, provavelmente em consequência da maior exigência física nas atividades de vida diária

Anthocyanidins and anthocyanins: colored pigments as food, pharmaceutical ingredients, and the potential health benefits

Anthocyanins are colored water-soluble pigments belonging to the phenolic group. The pigments are in glycosylated forms. Anthocyanins responsible for the colors, red, purple, and blue, are in fruits and vegetables. Berries, currants, grapes, and some tropical fruits have high anthocyanins content. Red to purplish blue-colored leafy vegetables, grains, roots, and tubers are the edible vegetables that contain a high level of anthocyanins. Among the anthocyanin pigments, cyanidin-3-glucoside is the major anthocyanin found in most of the plants. The colored anthocyanin pigments have been traditionally used as a natural food colorant. The color and stability of these pigments are influenced by pH, light, temperature, and structure. In acidic condition, anthocyanins appear as red but turn blue when the pH increases. Chromatography has been largely applied in extraction, separation, and quantification of anthocyanins. Besides the use of anthocyanidins and anthocyanins as natural dyes, these colored pigments are potential pharmaceutical ingredients that give various beneficial health effects. Scientific studies, such as cell culture studies, animal models, and human clinical trials, show that anthocyanidins and anthocyanins possess antioxidative and antimicrobial activities, improve visual and neurological health, and protect against various non-communicable diseases. These studies confer the health effects of anthocyanidins and anthocyanins, which are due to their potent antioxidant properties. Different mechanisms and pathways are involved in the protective effects, including free-radical scavenging pathway, cyclooxygenase pathway, mitogen-activated protein kinase pathway, and inflammatory cytokines signaling. Therefore, this review focuses on the role of anthocyanidins and anthocyanins as natural food colorants and their nutraceutical properties for health. Abbreviations: CVD: Cardiovascular disease VEGF: Vascular endothelial growth factor

Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccines

Both vector and mRNA vaccines were an important part of the response to the COVID-19 pandemic and may be required in future outbreaks and pandemics. The aim of this study was to validate whether immunogenicity differs for adenoviral vectored (AdV) versus mRNA vaccines against SARS-CoV-2, and to investigate how anti-vector immunity and B cell dynamics modulate immunogenicity. We enrolled SARS-CoV-2 infection-naïve health care workers who had received two doses of either AdV AZD1222 (n = 184) or mRNA BNT162b2 vaccine (n = 274) between April and October 2021. Blood was collected at least once, 10-48 days after vaccine dose 2 for antibody and B cell analyses. Median ages were 42 and 39 years, for AdV and mRNA vaccinees, respectively. Surrogate virus neutralization test (sVNT) and spike binding antibody titres were a median of 4.2 and 2.2 times lower, respectively, for AdV compared to mRNA vaccinees (p < 0.001). Median percentages of memory B cells that recognized fluorescent-tagged spike and RBD were 2.9 and 8.3 times lower, respectively for AdV compared to mRNA vaccinees. Titres of IgG reactive with human adenovirus type 5 hexon protein rose a median of 2.2-fold after AdV vaccination but were not correlated with anti-spike antibody titres. Together the results show that mRNA induced substantially more sVNT antibody than AdV vaccine, which reflected greater B cell expansion and targeting of the RBD rather than an attenuating effect of anti-vector antibodies. ClinicalTrials.gov Identifier: NCT05110911